DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Wainberg ZA, Segal NH, Jaeger D. , et al.
Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC).
J Clin Oncol 2017;
35: 4071-4071
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.